Effects of single administration of palatinose on metabolisms in patients with non-alcoholic fatty liver disease

Effects of single administration of palatinose on metabolisms in patients with non-alcoholic fatty liver disease - Effects of palatinose on metabolisms in patients with non-alcoholic fatty liver disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025866

Enrollment

Registered

2017-01-26

Start date

2017-01-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver disease

Interventions

palatinose/sucrose sucrose/palatinose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who can be treated by oral administration Patients who agreed this study with written informed consent

Exclusion criteria

Exclusion criteria: Diabetic patients with HbA1c > 8.0 Severe complication of diabetes mellitus Severe cardiovascular disease Severe liver disease Patients who can not be treated by oral administration Severe renal disease Risk of esophageal varix rupture Heart failure Diabetic patients treated with alpha-glucoseidase inhibitor

Design outcomes

Primary

Measure	Time frame
Changes in glucose and lipid metabolisms (glucose, insulin, free fatty acids, GLP-1, GIP-1, FGF-21) 180 min. after palatinose administration	—

Countries

Japan

Contacts

Public ContactTakumi Kawaguchi

Kurume University School of Medicine Division of Gastroenteorlogy, Department of Medicine

takumi@med.kurume-u.ac.jp0942-35-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026